Australian Clinical Labs Limited

ASX:ACL Rapport sur les actions

Capitalisation boursière : AU$515.3m

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Australian Clinical Labs Gestion

Gestion contrôle des critères 4/4

Australian Clinical Labs' CEO is Melinda McGrath, appointed in Dec 2020, has a tenure of 3.67 years. total yearly compensation is A$1.18M, comprised of 74.2% salary and 25.8% bonuses, including company stock and options. directly owns 1.46% of the company’s shares, worth A$7.51M. The average tenure of the management team and the board of directors is 5.1 years and 3.3 years respectively.

Informations clés

Melinda McGrath

Directeur général

AU$1.2m

Rémunération totale

Pourcentage du salaire du PDG74.2%
Durée du mandat du directeur général3.7yrs
Propriété du PDG1.5%
Durée moyenne d'occupation des postes de direction5.1yrs
Durée moyenne du mandat des membres du conseil d'administration3.3yrs

Mises à jour récentes de la gestion

Recent updates

We Think Australian Clinical Labs (ASX:ACL) Is Taking Some Risk With Its Debt

Jun 20
We Think Australian Clinical Labs (ASX:ACL) Is Taking Some Risk With Its Debt

Are Investors Undervaluing Australian Clinical Labs Limited (ASX:ACL) By 46%?

Feb 21
Are Investors Undervaluing Australian Clinical Labs Limited (ASX:ACL) By 46%?

Is It Time To Consider Buying Australian Clinical Labs Limited (ASX:ACL)?

Dec 08
Is It Time To Consider Buying Australian Clinical Labs Limited (ASX:ACL)?

Here's Why We Think Australian Clinical Labs (ASX:ACL) Might Deserve Your Attention Today

Aug 14
Here's Why We Think Australian Clinical Labs (ASX:ACL) Might Deserve Your Attention Today

Australian Clinical Labs Limited (ASX:ACL) Just Reported Half-Year Earnings: Have Analysts Changed Their Mind On The Stock?

Feb 25
Australian Clinical Labs Limited (ASX:ACL) Just Reported Half-Year Earnings: Have Analysts Changed Their Mind On The Stock?

New Forecasts: Here's What Analysts Think The Future Holds For Australian Clinical Labs Limited (ASX:ACL)

Dec 22
New Forecasts: Here's What Analysts Think The Future Holds For Australian Clinical Labs Limited (ASX:ACL)

The Market Lifts Australian Clinical Labs Limited (ASX:ACL) Shares 31% But It Can Do More

Dec 21
The Market Lifts Australian Clinical Labs Limited (ASX:ACL) Shares 31% But It Can Do More

The Strong Earnings Posted By Australian Clinical Labs (ASX:ACL) Are A Good Indication Of The Strength Of The Business

Sep 01
The Strong Earnings Posted By Australian Clinical Labs (ASX:ACL) Are A Good Indication Of The Strength Of The Business

Analyse de la rémunération des PDG

Comment la rémunération de Melinda McGrath a-t-elle évolué par rapport aux bénéfices de Australian Clinical Labs?
DateRémunération totaleSalaireBénéfices de l'entreprise
Dec 31 2023n/an/a

AU$15m

Sep 30 2023n/an/a

AU$26m

Jun 30 2023AU$1mAU$873k

AU$36m

Mar 31 2023n/an/a

AU$55m

Dec 31 2022n/an/a

AU$73m

Sep 30 2022n/an/a

AU$126m

Jun 30 2022AU$2mAU$873k

AU$178m

Mar 31 2022n/an/a

AU$156m

Dec 31 2021n/an/a

AU$134m

Sep 30 2021n/an/a

AU$97m

Jun 30 2021AU$2mAU$875k

AU$60m

Mar 31 2021n/an/a

AU$79m

Dec 31 2020n/an/a

AU$98m

Sep 30 2020n/an/a

AU$70m

Jun 30 2020AU$2mAU$852k

AU$41m

Rémunération vs marché: Melinda's total compensation ($USD789.76K) is about average for companies of similar size in the Australian market ($USD838.87K).

Rémunération et revenus: Melinda's compensation has been consistent with company performance over the past year.

PDG

Melinda McGrath

3.7yrs

Titularisation

AU$1,175,644

Compensation

Ms. Melinda McGrath is Chief Executive Officer and Executive Director at Australian Clinical Labs Limited since December 19, 2020. She served as Chief Executive Officer and Executive Director at Clinical L...

Équipe de direction

NomPositionTitularisationCompensationPropriété
Melinda McGrath
CEO & Executive Director3.7yrsAU$1.18m1.46%
A$ 7.5m
Lana Hudson
Deputy Chief Financial Officerless than a yearpas de donnéespas de données
Anthony Friedli
Chief Operating Officer8.6yrspas de données0.38%
A$ 1.9m
Sean Jackson
Chief Information Officer9.6yrspas de donnéespas de données
Joe Geran
National Marketing Directorno datapas de donnéespas de données
Tony Landgren
National Medical Director & Chief Pathologist15.6yrspas de données0.42%
A$ 2.2m
Chris Brownlow
Chief Executive Officer of New South Wales & Australian Capital Territory13.6yrspas de donnéespas de données
Shae Seymour
Chief Executive Officer of WA/SA/NT6.6yrspas de donnéespas de données
Eleanor Padman
Company Secretary3.3yrspas de donnéespas de données
Rob Izzard
Chief Executive Officer of ACL Commercial Pathology1.6yrspas de donnéespas de données
Darren McKee
Chief Executive Officer of Victoria1.6yrspas de donnéespas de données

5.1yrs

Durée moyenne de l'emploi

Gestion expérimentée: ACL's management team is seasoned and experienced (5.1 years average tenure).

Membres du conseil d'administration

NomPositionTitularisationCompensationPropriété
Melinda McGrath
CEO & Executive Director3.7yrsAU$1.18m1.46%
A$ 7.5m
Michael Alscher
Non-Executive Chairmanless than a yearAU$190.00k0.14%
A$ 720.9k
Christine Bartlett
Independent Non-Executive Directorless than a yearpas de données0.010%
A$ 51.4k
Andrew Dutton
Independent Non-Executive Director3.3yrsAU$145.66k0.041%
A$ 210.5k
Nathanial Thomson
Non Executive Director3.7yrsAU$130.00kpas de données
Leanne Rowe
Independent Non-Executive Director3.3yrsAU$140.64k0.0025%
A$ 12.8k
Mark Haberlin
Independent Non-Executive Director3.3yrsAU$145.66k0.024%
A$ 122.1k

3.3yrs

Durée moyenne de l'emploi

64yo

Âge moyen

Conseil d'administration expérimenté: ACL's board of directors are considered experienced (3.3 years average tenure).